Supratim Ghosh

Supratim Ghosh

Auto-generated profile, based on publicly available information

Supratim Ghosh

Chittaranjan National Cancer Institute

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2009 in ACS Nano
Verified
Journal Article
Open access
SGSupratim Ghosh
Supratim Ghosh
SDSamrat Dutta
Samrat Dutta
EGEvan Gomes
Evan Gomes
DCDavid Carroll
David Carroll
RDRalph D'Agostino
Ralph D'Agostino
WGWilliam H Gmeiner
William H Gmeiner
Nanoparticles, including multiwalled carbon nanotubes (MWNTs), strongly absorb near-infrared (nIR) radiation and efficiently convert absorbed energy to released heat which can be used for localized hyperthermia applications. We demonstrate for the first time that DNA-encasement increases heat emission following nIR irradiation of MWNTs, and DNA-encased MWNTs can be used to safely eradicate a tumor mass in vivo. Upon irradiation of DNA-encased MWNTs, heat is generated with a linear dependence on irradiation time and laser power. DNA-encasement resulted in a 3-fold reduction in the concentration of MWNTs required to impart a 10 °C temperature increase in bulk solution temperature. A single treatment consisting of intratumoral injection of MWNTs (100 μL of a 500 μg/mL solution) followed by laser irradiation at 1064 nm, 2.5 W/cm2 completely eradicated PC3 xenograft tumors in 8/8 (100%) of nude mice. Tumors that received only MWNT injection or laser irradiation showed growth rates indistinguishable from nontreated control tumors. Nonmalignant tissues displayed no long-term damage from treatment. The results demonstrate that DNA-encased MWNTs are more efficient at converting nIR irradiation into heat compared to nonencased MWNTs and that DNA-encased MWNTs can be used safely and effectively for the selective thermal ablation of malignant tissue in vivo.

9 August 2013 in Nanotechnology Reviews
Verified
Journal Article
Closed access
PDF file
William GmeinerWilliam Gmeiner
William Gmeiner
SGSupratim Ghosh
Supratim Ghosh
Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great specificity through both active and passive targeting. In this review, we summarize recent literature that has broken new ground in the use of nanotechnology for cancer treatment with an emphasis on targeted drug delivery.

3 February 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
SGSupratim Ghosh
Supratim Ghosh
FSFreddie Salsbury
Freddie Salsbury
DHDavid A. Horita
David A. Horita
WGWilliam H. Gmeiner
William H. Gmeiner
We report, based on semi-empirical calculations, that Zn(2+) binds duplex DNA containing consecutive FdU-dA base pairs in the major groove with distorted trigonal bipyramidal geometry. In this previously uncharacterized binding motif, O4 and F5 on consecutive FdU are axial ligands while three water molecules complete the coordination sphere. NMR spectroscopy confirmed Zn(2+) complexation occurred with maintenance of base pairing while a slight hypsochromic shift in circular dichroism (CD) spectra indicated moderate structural distortion relative to B-form DNA. Zn(2+) complexation inhibited ethidium bromide (EtBr) intercalation and stabilized FdU-substituted duplex DNA (ΔT(m) > 15 °C). Mg(2+) neither inhibited EtBr complexation nor had as strong of a stabilizing effect. DNA sequences that did not contain consecutive FdU were not stabilized by Zn(2+). A lipofectamine preparation of the Zn(2+)-DNA complex displayed enhanced cytotoxicity toward prostate cancer cells relative to the individual components prepared as lipofectamine complexes indicating the potential utility of Zn(2+)-DNA complexes for cancer treatment.

1 March 2018 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SGSupratim Ghosh
Supratim Ghosh
SMSumana Mallick
Sumana Mallick
UDUpasana Das
Upasana Das
AVAjay Verma
Ajay Verma
UPUttam Pal
Uttam Pal
WGWilliam H. Gmeiner
William H. Gmeiner

27 August 2013 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
SGSupratim Ghosh
Supratim Ghosh
KUKamil B. Ucer
Kamil B. Ucer
RDRalph D'Agostino
Ralph D'Agostino
KGKen Grant
Ken Grant
JSJoseph Sirintrapun
Joseph Sirintrapun
William GmeinerWilliam Gmeiner
William Gmeiner

1 November 2013 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SGSupratim Ghosh
Supratim Ghosh
FSFreddie Salsbury
Freddie Salsbury
DHDavid A. Horita
David A. Horita
WGWilliam H. Gmeiner
William H. Gmeiner
The simultaneous binding of netropsin in the minor groove and Zn2+ in the major groove of a DNA hairpin that includes 10 consecutive FdU nucleotides at the 3′-terminus (3′FdU) was demonstrated based upon NMR spectroscopy, circular dichroism (CD), and computational modeling studies. The resulting Zn2+/netropsin: 3′FdU complex had very high thermal stability with aspects of the complex intact at 85 °C, conditions that result in complete dissociation of Mg2+ complexes. CD and 19F NMR spectroscopy were consistent with Zn2+ binding in the major groove of the DNA duplex and utilizing F5 and O4 of consecutive FdU nucleotides as ligands with FdU nucleotides hemi-deprotonated in the complex. Netropsin is bound in the minor groove of the DNA duplex based upon 2D NOESY data demonstrating contacts between AH2 1H and netropsin 1H resonances. The Zn2+/netropsin: 3′FdU complex displayed increased cytotoxicity towards PC3 prostate cancer (PCa) cells relative to the constituent components or separate complexes (e.g. Zn2+:3′FdU) indicating that this new structural motif may be therapeutically useful for PCa treatment. An animated interactive 3D complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:32